Literature DB >> 3759998

ELISA for the routine determination of antitoxic immunity to tetanus.

O Simonsen, M W Bentzon, I Heron.   

Abstract

Serum samples from 727 persons with different vaccination histories were assessed for tetanus antitoxin content in an enzyme linked immunosorbent assay (ELISA) and tested for tetanus toxin neutralization activity in mice in order to compare the results obtained by the two methods. Neutralizing antibody activities in sera from individuals previously completely vaccinated correlated well with results obtained by ELISA and the accuracy increased with increasing antitoxin concentration in serum. This correlation was observed in sera from persons vaccinated recently as well as in sera from persons vaccinated many years ago. In sera from persons with an incomplete vaccination history ELISA was found to be an unreliable tool for the prediction of in vivo results. Many of these sera had antitoxin levels by ELISA far above the in vivo values, probably due to the presence of non specific or low avidity antitoxin which is detected in ELISA. The lowest ELISA value reliably predictive of protective antibody activity in serum irrespective of vaccination history was found to be 0.16 IU/ml. It was concluded that ELISA is useful for larger population studies as an initial test, but sera with an antitoxin content below 0.16 IU/ml should also be assessed in a neutralization system.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3759998     DOI: 10.1016/0092-1157(86)90008-9

Source DB:  PubMed          Journal:  J Biol Stand        ISSN: 0092-1157


  18 in total

1.  Time resolved fluorometric immunoassay, using europium labelled antihuman IgG, for the detection of human tetanus antitoxin in serum.

Authors:  P A Maple; C S Jones; N J Andrews
Journal:  J Clin Pathol       Date:  2001-10       Impact factor: 3.411

2.  Determination of tetanus antibodies by a double-antigen enzyme-linked immunosorbent assay in individuals of various age groups.

Authors:  K Caglar; R Karakus; C Aybay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-08       Impact factor: 3.267

3.  An exploratory trial of cyclooxygenase type 2 inhibitor in HIV-1 infection: downregulated immune activation and improved T cell-dependent vaccine responses.

Authors:  Frank O Pettersen; Eirik A Torheim; Anders E A Dahm; Ingeborg S Aaberge; Andreas Lind; Malin Holm; Einar M Aandahl; Per M Sandset; Kjetil Taskén; Dag Kvale
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

4.  Levels of antibodies specific to tetanus toxoid, Haemophilus influenzae type b, and pneumococcal capsular polysaccharide in healthy children and adults.

Authors:  Uwe Schauer; Frank Stemberg; Christian H L Rieger; Wolfgang Büttner; Michael Borte; Simone Schubert; Helga Möllers; Frank Riedel; Udo Herz; Harald Renz; Wilhelm Herzog
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

5.  Enzyme-linked immunosorbent assay-based inhibition test for neutralizing antibodies to polioviruses as an alternative to the neutralization test in tissue culture.

Authors:  G Edevåg; B Wahren; A D Osterhaus; V A Sundqvist; M Granström
Journal:  J Clin Microbiol       Date:  1995-11       Impact factor: 5.948

6.  Immune response to other agents of calves persistently infected with bovine virus diarrhoea virus (BVDV).

Authors:  H Houe; I Heron
Journal:  Acta Vet Scand       Date:  1993       Impact factor: 1.695

7.  Diphtheria-tetanus overimmunization in children with no records: can it be prevented?

Authors:  J W Frank; R Schabas; R Arshinoff; R Brant
Journal:  CMAJ       Date:  1989-12-15       Impact factor: 8.262

8.  Results of a phase 1 study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children and young adults with brain cancer.

Authors:  Denise A Caruso; Lisa M Orme; Alana M Neale; Fiona J Radcliff; Gerlinda M Amor; Wirginia Maixner; Peter Downie; Timothy E Hassall; Mimi L K Tang; David M Ashley
Journal:  Neuro Oncol       Date:  2004-07       Impact factor: 12.300

9.  Neonatal tetanus in Peru: risk assessment with modified enzyme-linked immunosorbent assay and toxoid skin test.

Authors:  L Vernacchio; G Madico; M Verastegui; F Diaz; T S Collins; R H Gilman
Journal:  Am J Public Health       Date:  1993-12       Impact factor: 9.308

10.  Maternal infection with Trypanosoma cruzi and congenital Chagas disease induce a trend to a type 1 polarization of infant immune responses to vaccines.

Authors:  Nicolas Dauby; Cristina Alonso-Vega; Eduardo Suarez; Amilcar Flores; Emmanuel Hermann; Marisol Córdova; Tatiana Tellez; Faustino Torrico; Carine Truyens; Yves Carlier
Journal:  PLoS Negl Trop Dis       Date:  2009-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.